A 9-year-old halfway through chemotherapy sits curled beneath a thin blanket, cheeks flushed and lips cracked. The parent says the fever began an hour ago; the child reports mouth sores and has not eaten since yesterday. The infusion-center paperwork lists a recent low neutrophil count, but there is no central-line redness and the child is still answering questions. The first antibiotic has not yet been chosen.

— What’s your move? Read on.

Before you read
  • Which findings justify adding gram-positive coverage?
  • What complications besides infection must you actively screen for?

When to Think of It

Fever in a child receiving cytotoxic therapy—commonly defined as a single temperature ≥38.3°C or ≥38.0°C sustained for an hour—with known or possible neutropenia is an emergency. Also look for mucositis, line infection, hypotension, respiratory or neurologic symptoms, new weakness or back pain, and laboratory evidence of tumor lysis (rising potassium, phosphate, uric acid, or creatinine; falling calcium).

Sick or Not Sick

The key fork is stable versus septic/unstable, not how impressive the fever looks. Shock, altered mental status, respiratory distress, poor perfusion, or suspected leukostasis demands immediate resuscitation and escalation while antibiotics are prepared.

The First Fifteen Minutes

  • Obtain cultures from each central-line lumen and a peripheral site if feasible, CBC, chemistry, renal function, lactate if ill, and tumor-lysis labs—but do not delay antibiotics.
  • Fever with known/suspected neutropenia: cefepime 50 mg/kg IV (maximum 2 g/dose) every 8 hours; it covers common dangerous gram-negative pathogens, including Pseudomonas. Give promptly, ideally within 60 minutes.
  • Shock, prior resistant gram-negative infection, or local protocol indicating broader coverage: meropenem 20 mg/kg IV (maximum 1 g/dose) every 8 hours; it broadens coverage when cefepime may be inadequate. Confirm higher doses for selected indications with institutional guidance.
  • Add suspected catheter infection, skin/soft-tissue infection, pneumonia, hemodynamic instability, or known resistant gram-positive infection: vancomycin 15 mg/kg IV every 6 hours, adjusted with pharmacy monitoring; it adds resistant gram-positive coverage when these features raise that risk. Do not add routinely for fever alone.
  • Poor perfusion or shock: isotonic crystalloid 10 mL/kg IV, then reassess perfusion and lungs before repeating; this restores intravascular volume while limiting fluid overload.
  • Treat airway, breathing, and circulation problems in parallel; involve pediatric oncology early.

Definitive Care & Disposition

Admit febrile neutropenic children for oncology-directed management; ICU care is appropriate for shock, respiratory failure, altered mental status, or rapidly worsening laboratory abnormalities. Reassess cultures and antibiotics with oncology/infectious disease. Screen for concurrent tumor lysis, leukostasis, bleeding/coagulopathy, and spinal cord compression; urgent imaging and specialist-directed intervention may be needed for focal neurologic deficits or back pain.

How This One Kills

The dangerous failure is waiting for an ANC, culture, or a “sicker-looking” child before giving antipseudomonal antibiotics. Neutropenia can blunt local inflammatory signs, and deterioration may be abrupt.
The Differential — What Else Looks Like This
  • Viral illness — mild appearance does not exclude bacteremia in neutropenia; false reassurance delays antibiotics.
  • Central-line infection — line-site redness may be absent; missing it can leave the source uncontrolled.
  • Tumor lysis syndrome — electrolyte and renal abnormalities, often after therapy or with bulky disease, point away from isolated infection; missing it risks arrhythmia or seizure.
  • Leukostasis — respiratory or neurologic dysfunction with very high leukocyte burden; confusing it with uncomplicated fever delays urgent oncology-directed care.

The Second-Day Story

A child may be afebrile after antipyretics, present only with lethargy or poor feeding, or have no focal infection despite bacteremia. Older children may minimize symptoms, and steroids or neutropenia can erase expected inflammatory findings. Use the treatment timeline, recent counts, vital signs, and caregiver report—not a reassuring examination alone—to set the threshold for cultures and antibiotics.
Back to Our Patient
Back to our 9-year-old with cracked lips and a new fever: chemotherapy plus a recent low neutrophil count makes febrile neutropenia the working emergency, even though the child is still answering questions and the line looks normal. First, stratify for instability; the child is currently perfusing adequately without respiratory distress or altered mental status. Obtain cultures and urgent labs, then give cefepime promptly; add vancomycin only if a qualifying trigger emerges. Admit for oncology-directed monitoring and assess in parallel for infection, tumor lysis, and other treatment complications.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a 9-year-old receiving chemotherapy who presents with fever to 38.4°C and one day of poor intake and painful oral sores. The parent reports a recent low neutrophil count; there is no cough, dyspnea, focal abdominal pain, or redness or drainage at the central line. The child is alert, with warm extremities, brisk capillary refill, and no respiratory distress or focal neurologic deficit. Mucositis is present, but there is no clear bacterial source. I’m concerned for febrile neutropenia with risk of rapid progression, though the child is currently hemodynamically stable. I’ll obtain central and peripheral cultures and urgent CBC, chemistry, renal function, and tumor-lysis labs, then give IV cefepime without waiting for the ANC. I’ll discuss with pediatric oncology and admit, escalating coverage or level of care if instability or a specific indication develops.”

Study Directive

  • From memory, list the clinical triggers for empiric vancomycin in febrile neutropenia.
  • Rehearse a first-15-minute order set: cultures, labs, antibiotic choice, and instability reassessment.
  • Review tumor-lysis labs and practice identifying the dangerous direction of change in potassium, phosphate, calcium, uric acid, and creatinine.

Recent Literature

  • Review or guideline Pediatric Oncologic Emergencies
    Prusakowski MK, Cannone D · Hematol Oncol Clin North Am, 2017 · PMID 29078932 · cited 16×
    A broad reference for recognizing and stabilizing life-threatening complications in children with known cancer, including febrile neutropenia, tumor lysis syndrome, and oncologic compression syndromes.